Latest Breaking News On - Subject expert committee - Page 8 : comparemela.com

After WHO alert, Centre warns against use of cough syrups containing pholcodine

After WHO alert, Centre warns against use of cough syrups containing pholcodine
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.

Saurabh khannaRajeev singh raghuvanshiKavita bajeli dattNews serviceWorld health organisationExpert committee antimicrobialDrug controller generalDrugs controller generalSubject expert committee

DCGI warns doctors, patients to stop using pholcodine containing cough syrups citing safety concerns

WHO warns healthcare professionals and regulatory authorities of the risk of anaphylactic reactions in the people who took pholcodine containing cough syrups and cold remedies atleast 12 months prior to surgical procedures involving the administration of general anesthesia with NMBAS

Expert committee antimicrobial antiviralSubject expert committeeCough syrup

covid: DCGI grants Emergency Use Authorization to Gennova biopharma's Omicron-specific covid booster

The mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC).

Sanjay singhJitendra singhRajeshs gokhaleVaccine expert committeeDepartment of biotechnologyGennova biopharmaceuticals ltdBiotechnology industry research assistance councilClinical trial networksMinistry of scienceExpert committeeDrug control generalEmergency use authorizationGennova biopharmaceuticalsPrime ministerUnion ministerTrial networks

Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology

Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology
orissadiary.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissadiary.com Daily Mail and Mail on Sunday newspapers.

Rajeshs gokhaleJitendra singhSanjay singhMinistry of scienceVaccine development missionDepartment of biotechnologyVaccine expert committeeInterface agencyExpert committeeBiotechnology industry research assistance councilGennova biopharmaceuticals ltdMinistry of science technologyClinical trial networksGennova biopharmaceuticalsDrug control generalEmergency use authorization

DCGI grants EUA to Omicron-specific mRNA-based booster vaccine

The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC), has got a nod from the office of the Drug Control General of India (DCGI) for Emergency Use Authorization (EUA).

Rajeshs gokhaleJitendra singhSanjay singhMission implementation unit at biotechnologyInterface agencyMinistry of science technologyIndustry research assistance councilGennova biopharmaceuticals ltdClinical trial networksExpert committeeVaccine development missionVaccine expert committeeBiotechnology industry research assistance councilDepartment of biotechnologyMinistry of scienceDevelopment mission